Pregnant women exposed to these medications and healthcare providers are encouraged to report exposures: For Semaglutide: Contact Novo Nordisk at 1-877-390-2760 or [www.wegovypregnancyregistry.com]( For Tirzepatide: Contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) Please note that the above list is not complete, and it describes the most common side effects and risks
Federal law says Part D plans can't cover drugs prescribed for weight loss even though obesity is a serious health condition
As part of a balanced routine-healthy meals, regular activity, and enough sleep-it may help support appetite balance and long-term weight management
The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) has published guidelines on the verification pathway for new medicine applications
and (3) Screen Positive Rate for SDOH measure, beginning with the CY 2025 reporting period
Evidence suggests that CJC-1295 may extend GHRH-like activity, while GHRP-6 appears to act through ghrelin and possibly CD36 receptors
